Article Details

Kidney disease progression risk lower with DOACs vs. vitamin K antagonists in AF - Healio

Retrieved on: 2022-10-06 19:02:25

Tags for this article:

Click the tags to see associated articles and topics

Kidney disease progression risk lower with DOACs vs. vitamin K antagonists in AF - Healio. View article details on HISWAI: https://www.healio.com/news/cardiology/20221006/kidney-disease-progression-risk-lower-with-doacs-vs-vitamin-k-antagonists-in-af

Excerpt

Disclosures: Carrero reports consulting for AstraZeneca and Bayer and receiving institutional grant support from Astellas, AstraZeneca and Vifor, all ...

Article found on: www.healio.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up